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Background: Infection with Coxiella burnetii, the cause of Q-fever, has never been detected in Norwegian animals.
Recognising the increasing prevalence of the infection in neighbouring countries, the aim of the study was to
perform a survey of Norwegian farmed ruminants for the prevalence of C. burnetii infection.
Results: Milk and blood samples from more than 3450 Norwegian dairy cattle herds, 55 beef cattle herds, 348 dairy
goat herds and 118 sheep flocks were serologically examined for antibodies against C. burnetii. All samples were
negative for antibodies against C. burnetii. The estimated prevalences of infected herds were 0 (95% confidence
interval: 0% - 0.12%), 0 (0% - 12%), 0 (0% - 1.2%) and 0 (0% - 10%) for dairy cattle herds, beef cattle herds, goat
herds and sheep flocks, respectively.
Conclusions: The study indicates that the prevalence of C. burnetii infection in farmed Norwegian ruminants is low,
and it cannot be excluded that Norway is free of the infection. It would be beneficial if Norway was able to
maintain the current situation. Therefore, preventive measures should be continued.
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Q-fever is a zoonotic disease caused by the intracellular
bacterium Coxiella burnetii. Most mammals and birds
are susceptible to the bacterium. Natural reservoirs are a
large variety of ticks and wild vertebrates, primarily
rodents [1], but farmed ruminants are considered the
main reservoir for transmission to humans [2,3]. Usually
infected animals are asymptomatic carriers. If symptoms
occur in mammals, they are most often related to the
reproductive system [4]. In cattle, C. burnetii infection
may cause metritis, reduced fertility and occasionally
abortions [5-7]. In sheep and goats, abortions and still-
births are more common than in cattle [6], and epi-
demics with abortion or non-viable progeny of more
than 50% of pregnant animals in goat herds [8] and
within groups of sheep flocks [9] have been reported.
Infection with C. burnetii in humans is often asymptom-
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reproduction in any medium, provided the orand/or hepatitis or in a severe chronic form with endocar-
ditis that may be lethal if not treated [10].
Infected animals, including healthy carriers, may shed
large quantities of the bacteria in amniotic fluids,
placenta and vaginal excretes in relation to birth, and
intermittently in milk and urine. C. burnetii develops
spore-like stages highly resistant to environmental influ-
ence. Animals, as well as humans, usually acquire the
infection by inhalation of material contaminated with
the bacterium (reviewed by [6]). A varying proportion of
animals develop antibodies against the bacterium, and
the presence of antibodies provides evidence of a recent
infection or past exposure [11]. Some individuals may
harbour the organism without seroconversion [12,13].
Therefore, serological tests should not be interpreted at
the individual level, but are suitable for investigation of
the epidemiological status in a population or herd [11].
For screening purposes, ELISA tests are often preferred
for practical reasons and because of their higher sensitiv-
ity than the complement fixation tests [11].
C. burnetii has a world-wide distribution. The infec-
tion is endemic in Southern and Central Europe, and the
last years an apparent increase in the occurrence hasl Ltd. This is an Open Access article distributed under the terms of the Creative
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Netherlands has experienced a concurrent epidemic in
goats and humans with more than 3500 notified human
cases until 2009, and extensive control measures have
been implemented in the small ruminant population
[14]. In Denmark, the infection is considered endemic
in cattle, with the prevalence still increasing [15]. In
Sweden, the bacterium was isolated from sheep placenta
in 1991 [16], and 8.5% of 1000 bulk milk samples from
cattle were positive for antibodies against C. burnetii
in 2008 [17]. Finland reported their first finding of
antibodies against C. burnetii in two heifers examined as
part of an export control of cattle in 2008 [18].
Infection with C. burnetii has never been detected in
animals in Norway, but the number of examinations for
C. burnetii has been limited. In 1990–91, 80 aborting
goats from 7 herds were examined [19] and from 2005
to 2009, 67 cattle, 12 sheep and 30 goats from 48, 3 and
1 herds respectively were serologically tested for anti-
bodies against C. burnetii (unpublished data, Annette
Kampen, Norwegian Veterinary Institute). In addition,
ruminants have been tested in connection with import
and export control. From 1989 to 2002, only twelve
human Q-fever cases were reported, and ten of these
individuals had acquired the infection abroad; the origin
of infection for the two remaining cases was not reported
[20]. Since 2002, Norwegian data on human Q-fever
cases have unfortunately not been collected centrally.
Recognising the increasing prevalence of infection in
neighbouring countries and the scarce knowledge of the
situation in Norwegian animals, the aim of this study
was to perform a serological survey of Norwegian farmed
ruminants for the prevalence of C. burnetii infection.
Methods
Sampling
The study was designed as cross-sectional studies of the
dairy and beef cattle, sheep and dairy goat populations
with the herd as the unit of concern.
A list of holding IDs of dairy cattle herds delivering
milk in July 2008 was obtained from the main dairy
company (Tine BA) receiving milk from more than 95%
of all dairy herds. In total, 6659 herds located in the
counties stfold, Hedmark, Oppland, Rogaland, Sør-
Trøndelag and Nord-Trøndelag (Figure 1) were consid-
ered eligible. Bulk milk samples from 600 randomly
selected dairy cattle herds were requested from the dair-
ies. From these, samples from 460 of the selected herds
were collected by the dairies and frozen before being
submitted to the laboratory.
In autumn 2010, bulk milk samples from dairy cattle
herds located in Southern Norway were collected as part
of the surveillance and control programme for blue-
tongue [21]. Samples from 3317 herds originating from13 counties (Figure 1) were collected by the dairies and
frozen before being submitted to the Norwegian Veter-
inary Institute. Of these, sufficient material was available
from 3289 different herds, and these were included in
the present study.
A total of 1864 beef cattle herds from the counties
stfold, Hedmark, Oppland, Rogaland, Sør-Trøndelag
and Nord-Trøndelag were registered in the register of
production subsidies in July 2007 (Norwegian Agricul-
tural Authority). Among these, 238 cattle herds had
been randomly selected for the surveillance programme
for enzootic bovine leukosis [22]. Only herds which
had submitted at least ten blood samples by the end of
October 2008 were considered eligible, leaving 85 herds
eligible for the study. From these, ten blood samples
from each of 55 randomly selected herds were examined
in the present study.
Bulk milk samples from a total of 348 goat herds from
the whole country, constituting 80% of the total dairy
goat population in Norway, were included in the present
study. The bulk milk samples had originally been sub-
mitted in March 2009 for examination for antibodies
against caprine arthritis-encephalitis virus as part of the
disease eradication programme Healthier goats [23].
From 2006 to 2008, 1179 sheep flocks from 126 differ-
ent breeding groups (ram circles) had been examined in
the surveillance programme for maedi/visna [24]. A ran-
dom selection of 130 sheep flocks covering all the 126
ram circles was performed. Material from 118 of these
flocks was available, and five blood samples from each
flock were further examined in the present study.
The study was performed in agreement with Norwegian
animal welfare regulations, in which the collection of
blood samples is exempt from specific approval [25].
Laboratory methods
All serum and bulk milk samples were tested using the
CHEKIT Q-Fever Antibody ELISA Test Kit (IDEXX
laboratories, Westbrook, WE, USA) following the manu-
facturer’s instructions, where the optical densities (OD)
of the sample and the positive control are corrected by
subtracting the OD value of the negative control, and
the ratio between the sample and the positive control
(S/P ratio) is calculated. The manufacturer considers an
S/P ratio of <30% as negative, 30% - 40% as inconclusive
and >40% as positive. In cases of inconclusive results,
the samples were retested in triplets. The bulk milk
samples were tested as described for single individual
milk samples. The test's ability to detect a single positive
animal in a bulk milk sample was estimated by examin-
ing eight positive individual milk samples that were seri-
ally diluted in serologically negative milk. The results
were used to estimate the herd sensitivity of the bulk
milk test (see Additional file 1).
Figure 1 The distribution of cattle herds sampled in a Norwegian study on seroprevalence of Coxiella burnetii. The counties in which
samples were collected in 2008 and 2010 are marked with blue and orange, respectively.
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The sample information and the results of the examina-
tions were entered into the laboratory information and
management system at the Norwegian Veterinary Insti-
tute. The information on the origin of the samples col-
lected in 2006 to 2009 was anonymized, and location
was registered at the county level.
Prevalence of positive herds in the population and the
corresponding 95% confidence intervals were estimated
by the data analysis module in Freecalc (Survey tool-
box, © Angus Cameron, Australia, 1998). As input to
Freecalc were used: the total number of herds, the num-
ber of examined herds, the number of positive herds, the
test specificity and the herd level sensitivity. For furtherdetails on the estimation of input parameters and the
calculations, see Additional file 1.Results
All samples examined were negative for antibodies
against C. burnetii. Three samples had inconclusive
results in the first test round. In the following retesting,
all triplets were negative and the samples were con-
cluded negative. The estimated prevalences with corre-
sponding 95% confidence intervals were 0 (0% - 0.12%),
0 (0% - 12%), 0 (0% - 1.2%) and 0 (0% - 10%) for dairy
cattle herds, beef cattle herds, goat herds and sheep
flocks, respectively (Table 1).
Table 1 Results of serological examination for antibodies








Dairy cattle 2008 6659* 460 0 0-1.0
Dairy cattle 2010 6673** 3289 0 0-0.12
Beef cattle 1864* 55 0 0-12
Dairy goats 429 348 0 0-1.2
Sheep 15101 118 0 0-10
The total number of herds in the population, number of herds examined,
and estimated prevalence of positive herds with 95% confidence intervals (CI)
are given.
* In the six counties included in the study.
** In the 13 counties included in the study.
Kampen et al. BMC Veterinary Research 2012, 8:59 Page 4 of 6
http://www.biomedcentral.com/1746-6148/8/59Discussion
Antibodies against C. burnetii were not detected in the
present study, giving no indication of any current or pre-
vious infection with C. burnetii in farmed Norwegian
ruminants. If C. burnetii infection should be present,
despite the results of this study, the prevalence in dairy
cattle is at any rate low. In Norway, the farmed ruminant
species cannot be considered as epidemiologically separ-
ate populations as holdings having combined production
with several species and sharing of pasture between vari-
ous ruminant species are common practise. Presence
of C. burnetii infection in beef cattle herds, dairy goat
herds or sheep flocks would presumably have led to
infected dairy cattle as well, indicating that if the infec-
tion is present, the prevalence is probably low also in
these populations.
The facts that C. burnetii infection has never been
detected in abortion cases from ruminants [19] and that
humans with C. burnetii infection acquired within
Norway has never been reported [20], support that the
prevalence of this infection in farmed ruminants is low
if present at all. Furthermore, Norway has an isolated
geographical location in Northern Europe, and the
number of imports of domestic animals has been limited
with a total of 127 cattle, 284 goats and 189 sheep
imported from 2000 to 2010 [26]. Hence, the probability
of introduction of infectious diseases by live animals is
considered low. Currently, New Zealand is the only
country considered to be free from C. burnetii infection
based on animal surveys and no reports of indigenous
human cases [11,27]. Norway has been able to obtain
and maintain freedom from several other infectious dis-
eases in ruminants, such as bovine virus diarrhoea,
enzootic bovine leukosis, infectious bovine rhinotrachei-
tis, bovine spongiform encephalopathy, tuberculosis, and
ovine, caprine and bovine brucellosis [28,29]. It cannot
be excluded that Norwegian farmed ruminants are free
from C. burnetii infection as well.In the initial study of the cattle population only six of
the Norwegian counties were included. These counties
comprise the majority of the cattle population, have the
highest animal density, and most of the imported rumi-
nants have been destined for holdings within this area.
It was considered unlikely that the infection would be
absent from these areas, if present in Norway. Therefore,
the survey was targeted on these counties to increase
the probability of detecting the infection. In 2010, dairy
cattle from a wider geographical area were examined
leaving only four counties in which dairy cattle have not
been included in a survey for C. burnetii. These four
counties comprise less than 20% of the Norwegian cattle
population and have the lowest cattle density, and it was
considered unlikely that the prevalence should be higher
in these areas than in the examined areas.
The calculation of confidence intervals for the preva-
lence estimates was based on herd sensitivities that
were low for all tested populations (see Additional file
1). Despite these low sensitivity estimates, the present
studies documented a 95% CI of 0–0.12% in dairy cat-
tle and 0 - 1% in goats due to the considerable num-
ber of herds tested. Important input parameters for
the estimation of the herd sensitivity were the ELISA
test sensitivity and the within-herd prevalence. The
test is based on a tick-derived reference strain of C.
burnetii. The use of ELISA tests based on strains iso-
lated from ruminants has been recommended [30].
Beare et al. argue that there is a risk of cross-reactivity
with other pathogens with the use of whole bacteria of
the tick-derived reference strain, and the tests are not
able to distinguish between different strains of C. bur-
netii [31]. However, in this screening, differentiation
between strains was not intended, and false positive
results due to non-specific cross reactions did not
seem to occur. Only a limited evaluation of the ELISA
test has been provided by the manufacturer, and the
best available information was applied when calculating
the test sensitivity for individual samples and bulk milk
samples (see Additional file 1). Furthermore, the
within-herd prevalence of animals serologically positive
for C. burnetii was set to 5%, which is below the few
estimates that have been reported from serological
studies using ELISA (reviewed by [32]). Therefore, the
authors consider the calculated confidence intervals as
conservative estimates.
Conclusions
The study indicates that the prevalence in farmed Nor-
wegian ruminants is low, and it cannot be excluded that
Norway is free of the infection. In several European coun-
tries, the number of C. burnetii infections has increased,
resulting in an increasing number of human cases with
severe disease. There is no indication that C. burnetii
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tion for humans. It would be beneficial if Norway was
able to maintain the current situation in ruminants. Pre-
ventive measures such as compulsory import control,
increased awareness, biosecurity measures at farm level,
and surveillance for early detection of an introduction,
are potential measures to obtain this.
Additional file
Additional file 1: Estimation of 95% confidence intervals [33-35].
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